NCT05269121View on ClinicalTrials.gov

Bacteriophage Therapy in First Time Chronic Prosthetic Joint Infections

PHASE1/PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

September 30, 2022

Primary Completion Date

November 30, 2023

Study Completion Date

November 30, 2024

Conditions
Prosthetic Joint InfectionBacterial Infections
Interventions
BIOLOGICAL

Phage Therapy

Patient will undergo a DAIR procedure. After the DAIR, phage therapy will be administered in conjunction with antibiotic treatment.

Sponsors
All Listed Sponsors
lead

Adaptive Phage Therapeutics, Inc.

INDUSTRY

NCT05269121 - Bacteriophage Therapy in First Time Chronic Prosthetic Joint Infections | Biotech Hunter | Biotech Hunter